Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Showing 10 of 9 products
ImageCatalog NumberProduct NameSizePriceAdd to Cart
S100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C)MBS638077-01S100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C)
0.01 mg
Sign In for Pricing
S100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C)MBS638077-02S100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C)
5x 0.01 mg
Sign In for Pricing
S100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin, Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) discontinuedS0051-88PS100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin, Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) discontinued
10 µg
Sign In for Pricing
Colon disease spectrum with normal tissue array as control, including TNM, clinical stage and pathology grade with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, containing 34 cases of adenocarcinoma, 2 carcinoid, 20 metastatic carcinoma, 5 each of adenoma and polyp, 8 hyperplasia, 10 each of inflammation, 104 cases/ 208 cores, replacing CO2081aCO2081bColon disease spectrum with normal tissue array as control, including TNM, clinical stage and pathology grade with MMR (MLH1/PMS2/MSH2/MSH6 2017 Ventana MMR kit) IHC results, containing 34 cases of adenocarcinoma, 2 carcinoid, 20 metastatic carcinoma, 5 each of adenoma and polyp, 8 hyperplasia, 10 each of inflammation, 104 cases/ 208 cores, replacing CO2081a
1 Each
Sign In for Pricing
Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961aNMET961Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961a
1 Each
Sign In for Pricing
LASP1, Control Peptide (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50)148128LASP1, Control Peptide (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50)
100 µg
Sign In for Pricing
Colon carcinoma, metastatic carcinoma and colon adenoma tissue array with colon tissue as control, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 98 cases/100 cores, replacing CO1005CO1005aColon carcinoma, metastatic carcinoma and colon adenoma tissue array with colon tissue as control, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 98 cases/100 cores, replacing CO1005
1 Each
Sign In for Pricing
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases/80 cores, replacing TH809TH809aThyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases/80 cores, replacing TH809
1 Each
Sign In for Pricing
LASP1, Control Peptide (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50)148127LASP1, Control Peptide (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50)
100 µg
Sign In for Pricing
ErbB2, Control Peptide (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL)149214ErbB2, Control Peptide (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL)
50 µg
Sign In for Pricing